Form D · Other

Clinical Ink, Inc.

Winston Salem, NC · CIK 0001496558

Offering snapshot reported May 18, 2018 · SEC filing

Reported sold
$5.31M
Indefinite offering
Investors reported
5
Form D · investor count
Minimum accepted
$2.65K
Reported outside-investor minimum
First sale
May 9, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 18, 2018Initial$5,314,013No comparison5SEC filing
Dec 28, 2017Initial$1,700,000No comparison9SEC filing
Apr 7, 2015Amendment$9,860,223$0vs Apr 2, 201521SEC filing
Apr 2, 2015Initial$9,860,223No comparison21SEC filing
Oct 29, 2013Initial$1,300,000No comparison18SEC filing
Dec 8, 2011Initial$3,132,000No comparison9SEC filing
Jul 14, 2010Initial$400,000No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-312809

Source: Form D, filed May 18, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Stephen H. Coltrin Director
Roger La Vern Davenport Director
Todd Foley Director
Ansbert Gadicke Director
Brad Geesaman Director
Morana Jovan Embiricos Director
Matthew King Director
Matt King Director
Robert Kniejski Director
Michael Lester Director
Thomas W Littlejohn, Iii Director, Executive, Promoter
Richard Malcolm Director
Scott Miltenberger Executive
Douglas E. Pierce, Jr. Director, Executive, Promoter
Christopher H. Ramm Director
Tony Rosenberg Director
Joe Schmidt Executive
Edward S. Seguine Director, Executive, Promoter
Edward S. Seguine, Jr. Director, Executive
Michael Sorensen Director
Phil Waugh Director
Philip Rs Waugh, Jr. Director

Issuer details

Industry: Other (See others in industry)

Address:
525 Vine Street Suite 130
Winston Salem, NC, 27101